We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
When grains like wheat and barley are stored in sheds and silos for long periods of time, there is a risk of damage from insect infestations and mould. Long-term storage losses can be up to 20% and there is currently no single way to verify the moisture and temperature of grains being held.
Existing grain-monitoring solutions measure only one variable and have limited reach. Crover Ltd’s remote monitoring device provides real-time data across a range of measurements including temperature and moisture through the whole silo. It does this by using sensors in a small robotic device called a Crover. Similar to a drone’s wings in air, or a boat’s rotor in water, it uses a patented method to move through solid grains and build up a map of conditions within the grain storage unit.
Lorenzo Conti, founder of Crover, made his breakthrough when researching his doctorate in granular physics at the University of Edinburgh. He developed a method for moving through groupings of solid particles like sand, grains and powders. His company patented the core technology for locomotion in bulk solids and is now developing a version of the probing device that can be tested and reviewed by potential buyers.
Lorenzo’s robot system will allow customers such as farmers, brewers, cooperatives, as well as grain merchants, to identify adverse conditions in their stock. The potential for the technology is substantial. In one year, one Crover could save up to 380 tonnes of grain from damage.
Crover has won a dozen prizes and competitions in the last couple of years and as well as seed funding. The company now has five full-time members staff and an international Patent Corporation Treaty application pending. Potential future applications for the innovation include subterranean exploration and the recovery of underground objects buried in terrains like desert sand and the Moon’s lunar soil.
Lorenzo says: “Looking back over the last 12 months I can see how I’ve made the steps from being a researcher to becoming an entrepreneur. The Enterprise Fellowship and Higgs Centre for Innovation, Edinburgh, have made sure that I had a clear path to follow.”
2018 – Shell Livewire – ‘Smarter Future’
2018 – Climate Launchpad Global – third place (highest UK team placement ever)
2019 – Started first on-site tests
2019 – DR Lorenzo Conti was awarded with an Enterprise Fellowship
2020 – Chivas Venture global award
2020 – UK patent covering the core technology for locomotion in bulk solids granted (GB2567898)
Visit their website: www.crover.tech
Christine Boyle was working as the managing director of her family roofing business when she realised that there was huge potential for the collection of solar heat energy on the large commercial flat roofs that her company constructed. Solar thermal is a renewable energy that is 70% efficient, produces the lowest carbon emissions, and is easily generated on site, but had not been widely used because of its expense, weight and inflexibility with existing architecture.
Christine set up Senergy Innovations to create the next generation of solar thermal panels. She worked with Queen’s University Belfast and the University of Ulster to produce the product, ensuring that the renewable energy panels addressed the problems that previous solar thermal panels faced as well as making panels that appealed to consumers and architects.
Senergy Innovations’ solar thermal panel is made from 100% polymer plastic, making it 50% cheaper to manufacture and install than existing products. The panels incorporate carbon nanotube materials that enhance the thermal performance and mechanical strength, which ensures that they are durable. The module panels are lightweight, and allow integrations with both existing and new buildings, so that renewable thermal energy can be easily generated on site.
Senergy’s solar thermal panels are affordable, durable and easy to integrate, creating a renewable energy solution that is competitive with gas and oil.
A lack of smart energy storage options is linked to poor energy distribution in developing countries and inefficient energy management in developed ones.
Dr Enass Abo-Hamed, CEO and Co-Founder of H2GO Power, has engineered new hydrogen-based energy storage units that use patented catalyst that allow energy to be released on demand.
This clean, low-cost energy storage solution has the capacity to store five to ten times as much energy as their battery equivalents. It could impact energy storage at every scale, from the provision of low-weight energy for drones to large-scale energy storage for national grids.
As an innovator with a strong drive to generate social impact, Enass Abo-Hamed aims to harness the technology’s abilities to utilise excess renewables, and facilitate reliable distribution of power in countries where energy supply is intermittent.
Initiatives are underway to penetrate the fast-growing, green energy market in remote islands, where H2GO Power’s Hydrogen based fuel units would offer a clean, low-cost solution for round-the-clock power.
There is also significant industrial interest from companies keen to explore other ways this disruptive technology can support smarter energy management.
Enass was awarded the 2017 Enterprise Hub Fellowship to help grow and develop her start-up, H2GO Power.
Caristo Diagnostics has patented a test that analyses CT heart scans for signs of inflammation in the coronary arteries, which is a key process in the lead up to heart attacks. The company uses algorithms and artificial intelligence to detect biomarkers in a patient’s CT scan to predict the likelihood of that person having a heart attack. The results can be used by healthcare providers to suggest risk-reduction schemes and deploy appropriate treatments for the patient.
Dr David Schottlander is the Chief Technical Officer at Caristo, responsible for research, development and system operations. David joined the SME Leaders programme in 2020 and hopes to use the mentoring and training it provides to help maintain the high performance culture across the R&D team as it scales to support the company’s growth.
Caristo’s software will soon be launched in the UK and US. Once it gets regulatory approval, the company will market its software as a service, with healthcare providers sending patients’ CT scans for analysis. By the end of 2021, the clinical services should be in regular use by early adopters leading to mass market implementation.
Caristo’s innovation will help change medical intervention from being reactive to proactive. It will increase the opportunities to avoid fatal heart attacks and could save billions of pounds in cardiac care worldwide.
There are more than 100,000 strokes in the UK each year. Almost two-thirds of stroke survivors leave hospital with a disability and in need of rehabilitation, with arms and hands most commonly affected.
Through his digital health startup Neurofenix, Guillem Singla Buxarrais is seeking to increase the accessibility and effectiveness of post-stroke rehabilitation with the NeuroBall, a novel and cost-effective medical device making bold changes to stroke rehabilitation.
Physiotherapy exercises can be repetitive and boring, whereas the Neuroball encourages users to exercise the whole arm, from shoulder to fingers, through a set of entertaining games, keeping the user engaged in their therapy.
Engineered with stroke survivors and physiotherapists from inception, the mobile application and handheld controller is a user-friendly device that helps people to regain function in an enjoyable way, as verified in user testing.
Guillem’s experience of volunteering in stroke rehabilitation motivated him to ensure that stroke survivors and physiotherapists were involved with the engineering of the device from inception. The mobile application and handheld controller is user-friendly and helps people to regain function in an enjoyable way, as verified in user testing.
The Neuroball has been engineered to sensitively monitor recovery. It shows stroke survivors their progress, and they can share results with a supportive online community, helping them to feel re-connected with family, friends and other survivors.
Guillem was awarded a 2017 Enterprise Fellowship supported by the Royal Commission for the Exhibition of 1851 to continue developing this technology and the Neurofenix team has grown rapidly as a result. It is also supported by the Nominet Trust and Entrepreneur First.
"The Enterprise Fellowship had a profound impact on Neurofenix’s progress and reducing our time to market. Our mentor and the Enterprise team provided invaluable support throughout."
Oliver has spent over five years as part of a team developing clinical probes that could revolutionise cancer screening. They are committed to enabling on-the-spot cancer diagnosis with minimal discomfort for patients - and without an anxious wait for results.
The group has developed a proprietary method of using small probes using fibre optics to direct laser light onto cells. They then analyse the interaction of this light with the molecules inside. This provides a molecular ‘fingerprint’ to identify different types of cells and any cancerous changes within them.
Using this technique can yield almost instantaneous results and is both faster and more objective than current testing. Traditional testing involves sending tissue that has been surgically removed to a lab to be analysed by a pathologist, a process that is traumatic for the patient and costly for the system.
The new process has been demonstrated to be at least as accurate as conventional gold standard pathology. However it doesn’t require the removal of tissue and allows for the immediate intervention and ongoing monitoring by clinicians.
In future, the technology is seen to have many other clinical applications as well as this humane testing process.
The technique has already undergone extensive tests on human tissue at Gloucestershire Hospitals NHS Foundation Trust, with one of the probes set to begin clinical trials within 18 months.
Smell disorders can detrimentally impact a person’s wellbeing. For example, when someone loses their sense of smell it can mean that food loses its flavour or their social interactions are impaired. This is especially relevant among an ageing population.
Current technological solutions to measure and train people’s sense of smell are not standardised or accurate, and are based on manual approaches such as soaked pens and scratch-and-sniff saturated materials. These manual approaches have shortcomings including a lack of control over smell stimuli, consistency of the smell delivery parameters such as intensity and concentration and a lack of comparable digital performance records to determine changes over time.
Dr Emanuela Maggioni and Professor Marianna Obrist are co-founders of OWidgets (Olfactory Widgets). Their company is developing patented digital, personalised, and automated smell training solutions that will enable standardised, comparable, and replicable smell stimuli.
OWidgets is looking to develop opportunities beyond the health and medical sectors. Its technology has been used by a creative studio exploiting multisensory elements to enhance participants’ immersion in a virtual reality project that has been displayed at the World Economic Forum in Davos and has long-term installations in Singapore and New York.
OWidgets is now developing a cloud-based software solution to help with smell training, including digital performance records. Smell disorders are associated with early onsets of degenerative diseases such as dementia, Alzheimer’s and Parkinson’s. Retraining the brain to smell through regular exercises can positively impact cognitive capability and memory. An adaptive hardware system helps training usability and user experience, making it more engaging, and keeping people motivated to do the training regularly.
Dr Maggioni says: “We have partnered with Rockefeller University (SMELL-RS) to create the first automated and standardised smell test toolkit to measure smell capabilities and extending smell training. We aim to integrate the smell training into smell tests, akin to eye tests/hearing tests, as part of routine healthcare checks, promoting a culture of ‘sense of smell care’ and ‘smell physiotherapy’.”
She continues: “The Enterprise Fellowship has been a life-changing experience! The support of the mentors, the Enterprise team, the workshops and networking possibilities have been invaluable and positively impacted the growth and development of OWidgets.”
2017 – OWidgets receives equity-free funding from European Research Council’s Proof-of-Concept programme
2018-19 – OWidgets obtains its first international
clients and early technology adopters in the immersive experience sector
2019 – Dr Emanuela Maggioni was awarded an Enterprise Fellowship
2019 – OWidgets Ltd spun out from the University of Sussex
Visit their website: www.owidgets.co.uk
in every 300 people worldwide is classified as legally blind. Of these, most (up to 90%) have some remaining sight called residual
vision. This can be limited to an awareness of colour, light, shapes
and motion. Stephen and his team have developed a non-invasive visual
display that can be worn like glasses to enhance the usefulness of
The glasses work by detecting the three dimensional structure of nearby objects and preferentially highlighting the nearest and most important objects, such as people, faces and obstacles.
Traditional assistive technologies for the visually impaired usually involve touch or sound-based devices. Although useful, these older solutions are hard to learn and provide a fairly limited increase in quality of life and independence.
Stephen's company Oxsight (a spin-out of the University of Oxford) is currently refining the prototype into a new lightweight pair of glasses, and a market-ready device is expected soon. It will initially be sold online, and potentially made available on the high street in the future.
Every year an estimated 4.1 million patients in the European Union (EU) are affected by a Healthcare-associated infections (HCAIs). This is equivalent to one in twenty hospitalised patients, making it one of the most common adverse outcomes for hospital patients.
Dr Felicity de Cogan has engineered a novel protective coating with the ability to kill bacteria on contact. Developed at her University of Birmingham spin-out company, NitroPep, the technology bonds antimicrobial agents to metals and plastics so that bacteria are rapidly killed on contact.
Used in healthcare facilities, the technology has the potential to inhibit the contamination of surfaces, from door-knobs to surgical tables, helping to prevent the 37,000 deaths that are thought to be caused directly by HCAIs in Europe.
Trials have shown that treated metals remain effective in killing over 99% of bacteria for up to 10 years. The technology has been independently verified and has regulatory approval to be sold.
Led by Felicity, an award-winning innovator, NitroPep is already partnering with key companies to sell into the domestic healthcare market. The technology is also attracting interest from a diverse range of sectors, including transport, filtration and air conditioning.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Former Inaugural Chair of the Enterprise Committee and a long-standing Academy Fellow, Ian Shott CBE FREng has played a prominent role in establishing the Enterprise Hub. His track record of helping businesses in the engineering and life science sectors transform their approach and improve their vision, ambition, business models and enterprise value is an invaluable resource.
Ian is the Founder and former Executive Chair of contract pharmaceutical development and manufacturing company ARCINOVA, which he sold to Quotient Sciences in February 2021 and continues as Senior Advisor to the board. Ian is also the Managing Director at investment and advisory firm Shott Trinova. Prior to his specialist investment work at Shott Trinova, Ian was the founder and CEO of Excelsyn, which was sold to an American multinational in 2010. Earlier in his career he held numerous senior executive positions at multinational life science companies across the globe.
Ian has a wealth of experience with major industry bodies. He is formerly the Chair of the UK government’s Leadership Forum for Industrial Biotechnology and a Governing Board Member of Innovate UK. Ian is also Visiting Professor at Oxford, Nottingham and Newcastle universities.
“Apart from a deep-seated passion to change the entrepreneurial landscape in the UK and rediscover our legacy from the industrial revolution, I am highly excited by the prospect of engaging with new young talent and using my experience to accelerate and amplify their success. I’ve been involved in mentoring for over a decade but believe the Hub offers a very special opportunity to work with the brightest and best”.
Andy’s career in industry has involved co-founding over a dozen spin-outs and start-ups, three of which floated on stock markets. Virata floated on NASDAQ and at its peak had a market capitalisation of $5 billion.
His most prominent successes have come through RealVNC, which won the prestigious MacRobert Award in 2013, and Ubisense plc. Collectively, these two organisations have received five Queen’s Awards for Enterprise.
In academia, Andy heads the University of Cambridge’s Computer Laboratory and is an Honorary Fellow of Trinity Hall and Corpus Christi College. Elsewhere, he served as President of the IET between 2012 and 2013, and in 2007 received a CBE for services to the computer industry.
Andy is co-founder and Chairman of pioneering remote access software developers RealVNC and is also Professor of Computer Technology at the University of Cambridge. He was elected a Fellow of the Royal Academy of Engineering in 1996.
“My own career experiences have demonstrated just how important it is that the bridges between academia and industry are present and robust, and also what can be achieved when the relationship works to its potential. The Enterprise Hub offers an invaluable opportunity for exceptional academics to work with experienced industry figures and bring truly exciting new technology businesses to fruition.”
Naeem Alvi is an award-winning brand strategist and the founder of Notepad. After years of helping fast-growth SMEs and big brands such as Nike, Adidas and RBS Natwest to better leverage their brand, Naeem founded Notepad to connect big brand experience with ambitious tech companies that want to define and scale up their brands effectively and affordably.
Recent achievements include:
John is Professor of Optoelectronic Systems and Dean of transnational Education at the University of Glasgow.
He moved to Glasgow in 1986, where he established an internationally leading research group addressing linear and nonlinear integrated optoelectronic systems. He developed new integration technologies for photonic integrated circuits based on quantum well devices and quantum well intermixing, which ultimately led to the formation of the spin-out company Intense Ltd in 2000.
Intense developed the world’s most advanced integrated laser systems, bringing monolithic laser arrays together with electronic ASICs and optics for precise energy delivery in a range of applications from printing to material processing. The monolithic laser arrays pushed reliability and manufacturing yields to new levels.
John has extensive experience of operating in both academic and high-technology industrial environments, and as a result has an excellent understanding of spinning out IP and creating commercial value from an academic base.
He has been involved with several start-up companies including Kelvin Nanotechnology Ltd (1997-2000); Compound Semiconductor Technologies Ltd (1999-2000) and Intense Ltd (now Intense Inc) (2000-2009).
John was elected a Fellow of the Royal Academy of Engineering (FREng) in 2007; Fellow of the Royal Society of Edinburgh (FRSE) in 2000; Fellow of IEEE (FIEEE) in 2000 ‘for contributions to development of integrated optics based on semiconductor quantum well devices’; and Fellow of the Optical Society (FOSA) in 2016 for ‘for contributions to quantum and photonics technologies and systems in III-V compound semiconductors’.
Alastair is Head of Analytics and Machine Learning at MDRxTECH, Mishcon de Reya's digital transformation consultancy.
Alastair is a UCL Computer Science PhD with a background in computer vision, analytics, machine learning, blockchain, strategy, and technology innovation. He is an experienced manager and entrepreneur who has built teams in both large and small organisations. He is regularly called upon to audit, evaluate and provide guidance to large scale technology programmes for MDRxTECH clients. An entrepreneurial and dynamic problem solver, Alastair co-founded Satalia, which builds and applies AI technology to solve efficiency problems for organisations such as Tesco and PwC. He also co-founded the venture backed WeArePopUp.com, and helped establish the IDEALondon innovation centre with Cisco Systems.
Alastair continues to maintain an active teaching role in the UCL School of Management (MSc Business Analytics) and Peking University, Beijing (MBA Technology Strategy). His research interests include technology strategy, blockchain, smart contracting and computational law.
Brewster Barclay has been selling, marketing and product managing for more than 40 years in a wide variety of high technology industries including printed circuit boards, both manufacturing processes and capital equipment, 3D circuit boards, online advertising, optical sensors, military chip packaging, radar tubes and software engineering services. Brewster has worked at Zuhlke Engineering, e2v technologies, Clicktream Technologies, Orbotech and PCK Technology Kollmorgen.
The experience of launching new products and almost six years running an internet advertising startup led to Brewster giving back in the form of mentoring early stage and growth startups. He identified a massive gap in business development, sales support and strategy that angels, accelerators and VCs give to startups. He has focused solely on sharing his experiences in business development sales, sales techniques and the practicalities of day to day sales and lead generation.
He has mentored at the Royal Academy of Engineering for the past seven years as well as for Accelerate Cambridge, Seraphim Space Capital and many other groups.
Vida is a behavioural change coach with over seven years’ experience helping people think differently and positively change lives. She helps people to build connection and balance in order to create a sustainable future for themselves, others and the world. Vida does this as a speaker, trainer and coach, focusing on wellbeing, self-care, belief change, and motivation.
Having worked in prisons and schools as well as the public sector with non-clinical NHS staff and private sector for companies such Telefónica and Wavin, she has a unique insight to share.
Professor Alison Noble is the Technikos Professor of Biomedical Engineering, in the Department of Engineering Science at the University of Oxford, and Associate Head of MPLS Division. She is a Fellow of the Royal Society (2017), the Royal Academy of Engineering (2008) and the President of the Medical Image Computing and Computer Assisted Interventions (MICCAI) Society, the international society in biomedical image analysis.
Alison’s research interests are in computer analysis of clinical and biological images and the development and translation into clinical practice of novel methodologies that provide new diagnostic and therapeutic image based biomarkers and software tools for image-based quantification and decision-making. Her research group works in close collaboration with clinicians and industry players. She is also a Founder and the Chief Technology Officer of a university spin-out company that is commercialising research from her laboratory (Intelligent Ultrasound Ltd).
She returned to Oxford as a University Lecturer in 1995 to set up a biomedical image analysis group. Biomedical image analysis has since grown to be the largest biomedical engineering activity in Oxford.
Alison has played a leading role in setting up the biomedical engineering undergraduate and postgraduate biomedical engineering teaching and training (MSc and CDT) programmes at Oxford over the last decade. She is a member of both the Oxford University’s Research and Education Committees (from Oct 2013), and has served or currently serves on a number of committees of the Royal Academy of Engineering and other national organisations as well as numerous research funding agency panels.
Bill is a leading scientist worldwide in the field of Medical Materials. His major research contributions have been recognised by numerous international awards, medals and memberships.
He has been the Professor of Medical Materials at the University of Cambridge; served as Director of Cambridge Pfizer Institute for Pharmaceutical Materials Science; Cambridge Director of CMI Interdisciplinary Research Cluster in Biomaterials and Tissue Engineering and Director of University of London Interdisciplinary Research Centre (IRC) in Biomedical Materials. He has been Head of Department, Dean, and Governor at Queen Mary University of London.
He has been the editor of the Journal of The Royal Society: Interface, the Journal of Materials Science: Materials in Medicine, the Journal of Materials Science, and of the Journal of Materials Science Letters.
Bill is Emeritus Professor of Medical Materials in the University of Cambridge. He is internationally recognised for his pioneering research contributions to biomaterials for medical devices, with awards including the Royal Academy of Engineering Prince Philip Gold Medal; the Royal Society Armourers and Brasiers Company Medal; the Kelvin Medal; the European Society for Biomaterials George Winter Award; the Japanese Society for Biomaterials Medal; the Institute of Materials Griffiths Medal and Chapman Medal; the UK Society for Biomaterials President's Prize; the Acta Metallurgica H.H. Holloman Award and the International Union for Physical Sciences and Engineering in Medicine Award of Merit.
Professor Bonfield's exceptional interdisciplinary contribution has been recognised by his election to all three UK National Academies as a Fellow of the Royal Society (FRS), a Fellow of the Royal Academy of Engineering (FREng) and a Fellow of the Academy of Medical Sciences (FMedSci).